Moreover, the survival probability for CRC patients presenting the high and low expression of TMEM182, MCM9, and LRRFIP1 was analyzed and visualized using the TIMER2.0 platform and TCGA database (Supplementary Figure S3) [14,27]. Here, LRRFIP1 is linked to colorectal carcinoma.